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A B S T R A C T
Despite advances in surgical technique and implant materials, cataract surgery in patients with uveitis is still a
challenging procedure. We retrospectively evaluated postoperative outcomes of cataract surgery in 35 eyes of 29 pa-
tients with uveitis. Phacoemulsification with posterior chamber intraocular lens implantation was performed in all
eyes. Postoperative evaluations were performed at day 2, and then at 7 days, 1, 3, and 6 months respectively. There
were 16 males, and 13 females, aged 31 to 68 years. Follow-up ranged from 4 to 35 months. At final follow-up 33 eyes
(94%) had an improvement in visual acuity compared with preoperative levels (p< 0,05). Giant cells were observed in
the intraocular lens optic in 7 eyes (20%). Posterior capsule opacification occurred in 10 eyes (29%). Clinical cystoid
macular edema was observed in 4 eyes, and 2 eyes required trabeculectomy with mitomycin C due to secondary glau-
coma. Cataract surgery in patients with uveitis leads to successful visual results after correct surgical timing, and ade-
quate anti-inflammatory therapy. There were no significant differences in the degree of inflammation after implanta-
tion of various types of intraocular lenses.
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Introduction
Cataract formation is a frequent complication in pa-
tients with uveitis. Its incidence can be as high as
50%1–2, resulting from recurrences of inflammation and
steroid use. Cataract surgery in such patients presents
many challenges due to the underlying systemic patho-
logy3–5, chronic preoperative inflammation, and the de-
velopment of complications. Because of those difficul-
ties, cataract surgery in the past was performed either
as intracapsular or extracapsular cataract extraction,
without the implantation of an intraocular lens6. The is-
sue of implantation of intraocular lenses in patients
with uveitic cataracts was addressed differently by dif-
ferent authors. Some authors advocated that intraocu-
lar lenses were contraindicated in uveitic eyes, because
they were thought to cause an inflammatory response7.
On the contrary, other authors8 published successful
outcomes after cataract extraction and intraocular lens
implantation in uveitic cataract.
Initially, due to technological restrictions, and con-
cerns about postoperative complications, intraocular
lenses were implanted only in carefully selected pa-
tients, such as those with Fuchs' heterochromic uvei-
tis9–10. Later, with advances in surgical techniques of
cataract extraction, particularly with the more wide-
spread use of small incision phacoemulsification sur-
gery, intraocular lenses were being implanted in pa-
tients with other types of uveitis as well11. Nowadays,
there is a great choice of various intraocular lenses
available on the market. The proper choice of intraocu-
lar lens regarding its material and design is important
for the postoperative outcome. To date, few studies have
addressed the safety and efficacy of implanting poste-
rior chamber intraocular lens of various materials in
uveitic eyes, with different outcomes12–14.
This retrospective study reports postoperative out-
comes after cataract extraction and posterior chamber
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implantation of three different types of intraocular len-
ses in patients with uveitis.
Patients and Methods
We retrospectively reviewed 29 charts of uveitis pa-
tients who had cataract surgery and intraocular lens
implantation at the Eye Clinic, University Hospital
»Sestre milosrdnice« from January 2001 to December
2003. There were 16 men (19 eyes), and 13 women (16
eyes), with a median age at the time of surgery of 41
years (range 31–68 years). The median follow up was 21
months (range 4–35 months). Most patients were diag-
nosed as having an idiopathic chronic uveitis (12 pa-
tients), with the second largest group having Fuchs'
heterochromic uveitis (8 patients). Other diagnoses of
uveitis included ankylosing spondilitis (3 patients),
rheumatoid arthritis (5 patients), and sarcoidosis (1 pa-
tient). Anterior uveitis was found in 16 eyes (46%), in-
termediate in eyes (20%), posterior in 3 (9%), and panu-
veitis in 9 eyes (25%). The most common associated
ocular pathology was the presence of posterior synechia,
which was found in 29 eyes. Other, less common ocular
findings included pupillary membranes (3 eyes), cystoid
macular edema (3 eyes), and iris neovascularization (2
eyes). Glaucoma was present in 8 eyes, and was man-
aged with topical medications in 6 eyes. Three of those
eyes have also undergone a YAG laser iridotomy. Two
eyes required trabeculectomy due to uncontrollable
glaucoma. The indications for a cataract surgery were
the reduction of visual acuity and/or the need for fundus
monitoring. Preoperatively, uveitis had to be quiescent
for a minimum of three months, with no signs of active
inflammation (noted by Uveitis Scoring System as gra-
de 0 for anterior chamber cells and grade 1 or less for
flare). Preoperative anti-inflammatory treatment was
adjusted individually (Table 1.).
All patients were operated on by the same surgeon
(Z.M.) in peribulbar anesthesia. Pupils were dilated
with a combination of 2.5% phenylephrine (2.5% Neo-
synephrine; Sanofi-Aventis, Strassbourg, France), and
1% tropicamide (1% Mydriacyl; Alcon Laboratories, He-
mel Hempstead, UK) eye drops. Anterior chamber was
accessed either by a scleral tunnel approach, or by a
clear cornea incision. In cases of an inadequately dilat-
ing pupil, due to posterior synechia, synechiolysis with a
needle, or iris stretching with Beehler pupil stretcher
(Rhein Medical Inc., Tampa, Fla., USA), or a viscoelastic
(Healon GV, Pharmacia, Uppsala, Sweden) were uti-
lized accordingly. Careful anterior continuous
curvilinear capsulorhexis was then performed, followed
by phacoemulsification of the lens nucleus, irrigation
and aspiration of cortical lens material. Posterior cham-
ber intraocular lens was implanted in all patients. In 19
eyes (55%) we implanted a foldable acrylic intraocular
lens (Acrysof MA60BM, Alcon, Forth Worth, TX, USA),
in 11 eyes (31%) a foldable silicone intraocular lens
(Allergan SI40, Allergan Inc, Irvine, CA, USA), and in 5
eyes (14%) a heparin-surface-modified poly(methyl met-
acrylate) (HSM PMMA) IOL 809C (Pharmacia & Upjohn,
Uppsala, Sweden).
Subconjunctival injections of dexamethasone were
given at the end of surgery. Postoperatively, the degree
of intraocular inflammation was controlled with topical
antibiotics and corticosteroids, subconjunctival cortico-
steroid injections, and if necessary, with systemic corti-
costeroids. Postoperative evaluations were performed at
day 2, and then at 7 days, 1, 3, and 6 months respec-
tively. Ocular examination, slitlamp biomicroscopy, and
fundus examination were done in all cases, noting early,
as well as late postoperative complications (recurrence
of inflammation, raised intraocular pressure, cystoid
macular edema, giant cell deposits, and posterior cap-
sule opacification).
Data were presented as median and range. Differ-
ence in preoperative and postoperative visual acuity
was tested with Wilcoxon Signed Rank Test. Difference
in the giant cell deposits on different types of intraocu-
lar lens was tested with Fisher's Exact Test. P value of
less than 0.05 was taken as statistically significant.
Results
We analyzed 29 patients and 35 eyes. The patients
were followed for a minimum of 4, and a maximum of 35
months. We encountered following intraoperative com-
plications: zonular dehiscence in 2 eyes, posterior cap-
sule tear in 3 eyes, anterior chamber bleeding in 2 eyes,
iris damage in 3 eyes and filliform haemorrhage in 3
eyes. Despite those intraoperative complications, we
managed to implant an intraocular lens in the posterior
chamber in all eyes. Average preoperative visual acuity
was 0.15 (range 0.025 to 0.5), and average postoperative
visual acuity was 0.6 (range 0.05 to 1.0). 94% percent of
patients showed an improvement in visual acuity, while
79% of them had a visual acuity of 0.5 or better. The dif-
ference in preoperative versus postoperative visual acu-
ity was statistically significant (p=0.002). The most
common complication in the early postoperative period
was the recurrence of inflammation, which was noted in
8 eyes (23%), followed by raised intraocular pressure (6
eyes, 17%), and cystoid macular edema (4 eyes, 11%). In
the late postoperative period, posterior capsule opaci-
fication occurred in 10 eyes (29%), followed by posterior
synechiae (5 eyes, 14%). Other less common complica-
tions included secondary glaucoma in two and epiretinal
membrane formation in one patient. Giant cell deposits
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were found in 4 eyes with an implanted acrylic intra-
cular lens, in 2 eyes with a silicone intraocular lens, and
in one eye with a heparine surface modified PMMA
intraocular lens. There were no statistically significant
differences in the incidence of giant cell deposits (Figure
1.) among those three groups of intraocular lenses (Fi-
sher's Exact Test, p=0.54).
Discussion
Our results showed that the primary outcome, post-
operative best corrected visual acuity, improved in 94%
of eyes, and that 79% reached a visual acuity of 0.5 or
better. These results are comparable to other studies on
cataract extraction in patients with uveitis. Estafanous
et al.11, and Kang et al.15 reported visual improvement
in 95% and 96% of eyes, with final visual acuity of 0.5 or
better in 87% and 64% of eyes respectively. Final visual
acuity of less than 0.5 in our study was the result of
chronic cystoid macular edema, epiretinal membrane
formation, and secondary glaucoma. The most common
complication after surgery was the recurrence of inflam-
mation, which was seen in 8 eyes (23%). This is lower
than the rate reported by Estafanous et al11 and Foster
et al.4 (41% and 51% respectively). The reason for this
might lie partly in the fact that we performed phaco-
emulsification cataract extraction, a procedure that has
been shown to induce less inflammation in the early
postoperative period15, and partly in the type of uveitis.
Intraocular pressure seems to be only slightly af-
fected by cataract extraction. We found an intraocular
pressure increase in 6 eyes after cataract extraction.
However, those were the patients whose intraocular
pressure was elevated before the surgery as well. They
were all managed with additional topical medications.
Two patients with secondary glaucoma required trabe-
culectomy with mitomycin C. The rates of cystoid macu-
lar edema (11%), epiretinal membrane formation (3%)
and posterior synechiae (14%) were lower than those re-
ported by Foster et al.4 whose rates were 46%, 23% and
15% respectively. This can be explained by the use of
phacoemulsification technique in our series. However,
the rate of posterior synechiae in our series was higher
than the rate reported by Estafanous et al.11 (8%). Hol-
land et al.16 hypothesized that the continuous curvili-
near capsulorhexis used in phacoemulsification leaves a
smoother anterior capsule edge, unlike a can opener
technique used in extracapsular cataract extraction,
which in turn leads to a lower rate of posterior syne-
chiae. Even though we also performed continuous curvi-
linear capsulorhexis as Estefanous et al., our higher
rate of postoperative posterior synechiae can be partly
explained by a larger percentage of patients with preop-
erative posterior synechiae (83% vs. 50%). However, our
rate of cystoid macular edema (11%) was lower than the
rate of Estefanous et al, and comparable with the rate
reported by Harada et al.17. This finding can be ex-
plained by our lower rate of postoperative recurrence of
inflammation that required treatment (23% vs. 41%).
Intracoular lens biocompatibility, i.e. the inflamma-
tory response produced by an intraocular lens implant
is still a controversial issue in uveitic eyes. The develop-
ment in intraocular lens materials from polymethyl
methacrylate (PMMA) through heparine surface modi-
fied PMMA, to modern foldable hydrophilic acrylic, hy-
drophobic acrylic and silicone has led to a diminished in-
flammatory response and better biocompatibility18–23.
We implanted three different types of intraocular lenses
in our study: a heparin surface modified PMMA, hydro-
phobic acrylic, and silicone intraocular lenses.
The evaluation of giant cell deposits on the lens sur-
face showed no statistically significant difference be-
tween those three implanted materials in our study.
Rauz et al.12 evaluated the incidence of giant cell depos-
its and posterior capsule opacification on acrylic, sili-
cone and hydrogel intraocular lenses. Giant cells were
most often seen on acrylic biomaterial, but the differ-
ence was not statistically significant. There was no as-
sociation between posterior capsule opacification and
various lens biomaterials.
Alio et al.13 compared hydrophobic acrylic, silicone,
PMMA and heparin surface modified PMMA intraocu-
lar lenses in patients with uveitic cataract, and con-
cluded that the acrylic and heparin surface modified
PMMA lenses had the lowest incidence inflammation
recurrences. The highest incidence of posterior capsule
opacification was observed on silicone intraocular len-
ses. Formanek et al.14 evaluated hydrophilic acrylic, hy-
drophobic acrylic and silicone intraocular lenses in uve-
itic cataract, and concluded that hydrophilic acrylic
material had good uveal, but worse capsular biocompa-
tibility, the opposite being with hydrophobic acrylic ma-
terial. Silicone lenses performed a little better than hy-
drophobic acrylic intraocular lenses in terms of uveal
and capsular biocompatibility. Although our study has
limitations due to its retrospective nature, and a small
number of patients, with different types of uveitis, we
have shown that phacoemulsification and posterior
chamber intraocular lens implantation is safe and com-
parable with previous reports. However, the optimal
intraocular lens biomaterial is yet to be produced.





















Fig. 1. Incidence of giant cell deposits on different types
of intraocular lenses.
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We reported successful visual outcomes in our series
of patients, but good preoperative control of inflamma-
tion, correct surgical timing, and vigorous postoperative
supervision are essential for the success of surgery.
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POSTOPERATIVNI ISHODI NAKON IMPLANTACIJE INTRAOKULARNE LE]E U O^IMA
S KATARAKTOM I UVEITISOM
S A @ E T A K
Unato~ napretku u kirur{koj tehnici, kao i implantacijskim materijalima, operacija katarakte kod pacijenata sa
uveitisom je jo{ uvijek zahtjevan operacijski zahvat. Retrospektivno smo ocijenili postoperativne ishode operacije
katarakte u 35 o~iju kod 29 pacijenata s uveitisom. U svih pacijenata je na~injena fakoemulzifikacija sa implan-
tacijom intraokularne le}e u stra`nju o~nu sobicu. Postoperativni pregledi na~injeni su drugi postoperativni dan, te
nakon 7 dana, 1, 3 i 6 mjeseci nakon operacije. U studiju je uklju~eno 16 mu{karaca i 13 `ena, ~iji je raspon starosti
iznosio od 31 do 68 godina. Pacijenti su pra}eni najmanje 4, a najvi{e 35 mjeseci. Na posljednjoj kontroli 33 o~iju
(94%) je imalo pobolj{anje vidne o{trine u odnosu na preoperativnu vidnu o{trinu (p<0.05). Nakupine gigantskih
stanica na opti~kom dijelu intraokularne le}e zabilje`eno je u 7 o~iju (20%). Opacifikacija stra`nje kapsule dogodila se
u 10 o~iju (29%). Klini~ki vidljiv cistoidni makularni edem zabilje`en je u 4 oka, a 2 oka su podvrgnuta trabeku-
lektomiji sa mitomicinom C zbog sekundarnog glaukoma. Operacija katarakte kod pacijenata sa uveitisom dovodi do
uspje{nog oporavka vidne o{trine, ukoliko je zahvat proveden u optimalnom trenutku i uz adekvatnu protuupalnu
terapiju. Nije bilo statisti~ki zna~ajnih razlika u stupnju upale nakon implantacije razli~itih vrsta intraokularnih
le}a.
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